Insights - Puma Biotechnology (PUMA) shares ripped higher by 200% in after-hours trading on Tuesday with positive results from a late-stage trial of Puma’s experimental breast cancer drug, neratinib. The ExteNET … Continue Reading
Read NowInsights - With Sandoz deal, Anacor (ANAC) investors can get a little more comfortable with the upcoming commercial launch.
Read NowRecap - In the three trading sessions following the Fed’s semi-annual monetary policy report, in which the fed specifically called out small biotech equities as overvalued, the iShares … Continue Reading
Read NowInsights - Prana Biotech (PRAN) said on Thursday that after further analysis of a failed Alzheimer’s study, the company will likely move forward with lead drug candidate PBT2 in … Continue Reading
Read NowInsights - Tax inversion has been a trend in the biotech and pharmaceutical industry, involvinga U.S.-based company acquiring a smaller foreign company in order to reduce paid … Continue Reading
Read NowInsights - Pozen (POZN) shares dropped on news that the FDA has accepted for review the refiling of a NDA for two aspirin candidates, PA8140 and -32540. … Continue Reading
Read NowInsights - La Jolla Pharmaceutical (LJPC) shares jumped 21% in early trading on Tuesday following news that pipeline candidate LJPC-1010 demonstrated positive activity in a pre-clinical model … Continue Reading
Read Now
